Tuesday 12 December 2017
Contact US    |    Archive
PR
3 months ago

Ocugen Announces FDA Acceptance of Investigational New Drug Application for OCU310 (brimonidine/steroid combination therapy) and Initiates Proof of Concept Study for Treatment of Dry Eye Disease

MALVERN, Pa., Sept. 25, 2017 /PRNewswire/ -- Ocugen, Inc., a clinical stage biopharmaceutical compan

Read on the original site


Hashtags:   

Ocugen

 | 

Announces

 | 

FDA

 | 

Acceptance

 | 

Investigational

 | 

New

 | 

Drug

 | 

Application

 | 
Most Popular (6 hours)

Keith Chegwin obituary

- Theguardian

Most Popular (24 hours)

Most Popular (a week)

The Art of the Steal

- Sputniknews

Categories - Countries
All News
All Countries